Earli
Developer of cancer-programmable genetic constructs designed to turn on only in cancer cells and force them to be revealed. The company offers to force cancer cells to make synthetic biomarkers that d...
Valuation
$0
Share Price
N/A
Total Raised
$79.5M
Last Round
Unknown
Latest Funding Round
Unknown
Investors
+23 other investors